Revista Espanola De Medicina Nuclear E Imagen Molecular最新文献

筛选
英文 中文
Evaluación de la captación cardiaca incidental en la gammagrafía ósea en España: el estudio ECCINGO 西班牙骨闪烁成像中偶然摄取的心脏摄取量评估:ECCINGO 研究
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500020
F.J. de Haro del Moral , S. Aguadé Bruix , M.J. Tabuenca Mateo , M.P. Tamayo Alonso , L. Mohamed Salem , L. Bernal , D. Primiano , P. Tarilonte
{"title":"Evaluación de la captación cardiaca incidental en la gammagrafía ósea en España: el estudio ECCINGO","authors":"F.J. de Haro del Moral ,&nbsp;S. Aguadé Bruix ,&nbsp;M.J. Tabuenca Mateo ,&nbsp;M.P. Tamayo Alonso ,&nbsp;L. Mohamed Salem ,&nbsp;L. Bernal ,&nbsp;D. Primiano ,&nbsp;P. Tarilonte","doi":"10.1016/j.remn.2024.500020","DOIUrl":"10.1016/j.remn.2024.500020","url":null,"abstract":"<div><h3>Aim</h3><p>Myocardial uptake on bone scintigraphy has become useful for the detection of transthyretin cardiac amyloidosis (ATTR-CA). This study aimed to assess the prevalence of myocardial uptake in patients over 18 years of age with no clinical suspicion of cardiac amyloidosis (CA) who had undergone bone scintigraphy.</p></div><div><h3>Methods and results</h3><p>This was an observational, retrospective, multicenter study across 21 Spanish hospitals (September–November 2019). Of the 9864 scans analyzed (locally and centrally), incidental cardiac uptake was observed in 71 patients (0.72%), a prevalence that increased with age. A previous diagnosis of heart failure was found in 16.9% of patients with positive uptake, with<!--> <!-->&gt;50% in NYHA II. ATTR-CA was diagnosed in 10 patients, with a mean delay of 10.4 months (95% CI: 5.1-15.7). All were<!--> <!-->&gt;70 years old, primarily male, and had greater left ventricular hypertrophy than patients without a confirmed diagnosis (<em>p</em>&lt;<!--> <!-->0.0001). ATTR-CA patients had higher rates of orthostatic hypotension (30.0% vs. 3.8% in non-ATTR-CA; p<!--> <!-->=<!--> <!-->0.025).</p></div><div><h3>Conclusions</h3><p>This is the first retrospective, national, multicenter study evaluating the prevalence of incidental cardiac uptake in bone scintigraphy performed for non-cardiac reasons, showing a prevalence of 0.72% in this population. Referral of these patients may facilitate early diagnosis of CA with a resulting benefit for patients.</p></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500020"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2253654X24000283/pdfft?md5=9b700d264c6d0de207d3419e4e63f693&pid=1-s2.0-S2253654X24000283-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actualización sobre la protección radiológica de la glándula tiroides 甲状腺辐射防护的最新情况
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500026
M. Negre , S. Agramunt , N. Ferran , P. Paredes
{"title":"Actualización sobre la protección radiológica de la glándula tiroides","authors":"M. Negre ,&nbsp;S. Agramunt ,&nbsp;N. Ferran ,&nbsp;P. Paredes","doi":"10.1016/j.remn.2024.500026","DOIUrl":"10.1016/j.remn.2024.500026","url":null,"abstract":"<div><p>In recent years, concern about the effects of ionizing radiation on exposed individuals has led to the need to regulate and quantify the use of diagnostic and therapeutic techniques. Geopolitical events in recent times have also increased the population's perception of insecurity regarding ionizing radiation, and we increasingly face patients reluctant to undergo certain types of scans in our nuclear medicine services and, albeit less frequently, in radiology services. This article aims to summarise the extent to which ionizing radiation is present in our daily lives and how diagnostic and therapeutic procedures can affect our health, particularly from the perspective of their effects on the thyroid gland, one of the body's most radiation-sensitive organs.</p></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500026"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identificación de ganglio centinela axilar no detectado en cáncer de mama tratado con quimioterapia neoadyuvante 鉴定新辅助化疗乳腺癌患者未检测到的腋窝前哨结节
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500024
A. García-Ruiz, I. Martínez-Rodríguez, N. Martínez-Amador, N.V. Carvalho-Duarte, J. Jiménez-Bonilla, R. Quirce
{"title":"Identificación de ganglio centinela axilar no detectado en cáncer de mama tratado con quimioterapia neoadyuvante","authors":"A. García-Ruiz,&nbsp;I. Martínez-Rodríguez,&nbsp;N. Martínez-Amador,&nbsp;N.V. Carvalho-Duarte,&nbsp;J. Jiménez-Bonilla,&nbsp;R. Quirce","doi":"10.1016/j.remn.2024.500024","DOIUrl":"10.1016/j.remn.2024.500024","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500024"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Descifrando el futuro: desafíos y oportunidades de la medicina nuclear 解读未来:核医学的挑战与机遇
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500036
J.R. Garcia, R. Jover, M. Mila, A. Muxi, V. Vallejos, A. Garcia, E. Caballero
{"title":"Descifrando el futuro: desafíos y oportunidades de la medicina nuclear","authors":"J.R. Garcia,&nbsp;R. Jover,&nbsp;M. Mila,&nbsp;A. Muxi,&nbsp;V. Vallejos,&nbsp;A. Garcia,&nbsp;E. Caballero","doi":"10.1016/j.remn.2024.500036","DOIUrl":"10.1016/j.remn.2024.500036","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500036"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141843606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gestión de riesgo del tratamiento con radioyodo en el cáncer diferenciado de tiroides 分化型甲状腺癌放射性碘治疗的风险管理
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500029
J. Villena-Salinas , M.A. Sempere Alcocer , M. Gallego Peinado
{"title":"Gestión de riesgo del tratamiento con radioyodo en el cáncer diferenciado de tiroides","authors":"J. Villena-Salinas ,&nbsp;M.A. Sempere Alcocer ,&nbsp;M. Gallego Peinado","doi":"10.1016/j.remn.2024.500029","DOIUrl":"10.1016/j.remn.2024.500029","url":null,"abstract":"<div><h3>Introduction</h3><p>Patient safety is paramount in providing quality healthcare and constitutes a global concern for healthcare systems. Radioiodine treatment to patients with well-differentiated thyroid cancer is not without risks. The aim of this study is to identify, evaluate and mitigate the risks associated with this procedure.</p></div><div><h3>Materials and methods</h3><p>A single-centre descriptive study was conducted in which risk management was carried out by establishing a risk map using FMEA methodology.</p></div><div><h3>Results</h3><p>Based on the process map 6 sub-processes and 23 failure modes in the three phases of the treatment process were analysed. According to risk priority number (RPN), the sub-process with the highest risk was administrative management (RPN 82), followed by treatment per se and post-treatment imaging (both with RPN 70). An overall process RPN of 300 (156 pre-treatment, 74 treatment and 70 post-treatment) was obtained. Failures directly related to the patient pose a high risk. The implementation of verification systems, performing tasks earlier and providing quality medical information are the most relevant preventive measures to be implemented.</p></div><div><h3>Conclusions</h3><p>The application of the FMEA methodology in the risk management for radioiodine treatment is a valuable tool for improving the quality and safety of this process. The risk map has been able to identify failures at different stages, assess their causes and effects, prioritise the risks identified and implement preventive and corrective measures that can be monitored, ensuring the effectiveness of the actions taken.</p></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500029"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141847010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meningioma nasosinusal recurrente: perspectivas de la imagen con receptores de somatostatina 复发性鼻咽部脑膜瘤:体生长抑素受体的成像视角
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500014
A.S. Abdlkadir , R. Amarin , E. Estrada-Lobato , A. Al-Ibraheem
{"title":"Meningioma nasosinusal recurrente: perspectivas de la imagen con receptores de somatostatina","authors":"A.S. Abdlkadir ,&nbsp;R. Amarin ,&nbsp;E. Estrada-Lobato ,&nbsp;A. Al-Ibraheem","doi":"10.1016/j.remn.2024.500014","DOIUrl":"10.1016/j.remn.2024.500014","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500014"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ablación percutánea guiada por ecografía de nódulos tiroideos con [177Lu]Lu-MAA (LUTMA): estudio de viabilidad 经皮超声引导下用[177Lu]Lu-MAA(LUTMA)消融甲状腺结节:可行性研究
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500023
S. Sager , E. Akgun , M. Abuqbeitah , A. Nazari , N. Yeyin , E. Karayel , H. Pehlivanoglu , A. Aygun , H. Burcak Sayman
{"title":"Ablación percutánea guiada por ecografía de nódulos tiroideos con [177Lu]Lu-MAA (LUTMA): estudio de viabilidad","authors":"S. Sager ,&nbsp;E. Akgun ,&nbsp;M. Abuqbeitah ,&nbsp;A. Nazari ,&nbsp;N. Yeyin ,&nbsp;E. Karayel ,&nbsp;H. Pehlivanoglu ,&nbsp;A. Aygun ,&nbsp;H. Burcak Sayman","doi":"10.1016/j.remn.2024.500023","DOIUrl":"10.1016/j.remn.2024.500023","url":null,"abstract":"<div><h3>Purpose</h3><p>The main purpose is to evaluate the safety, and efficacy of <sup>177</sup>Lutetium labeled macroaggregated albumin (LUTMA) ablation of thyroid nodules.</p></div><div><h3>Material and methods</h3><p>Patients with confirmed benign nodules who were not candidate or did not accept surgery were enrolled. Under ultrasonography (USG) guidance, LUTMA which was produced in our department, was administered into the nodules. Nodule volumes were assessed via USG before the injection and at 1-week, 1-month, and 3-months post-treatment. We calculated the volume reduction rates (VRRs) for these intervals. To detect extranodular activity leakage, patients underwent SPECT/CT imaging at one hour, 24<!--> <!-->hours, and one week post-injection.</p></div><div><h3>Results</h3><p>Fifteen patients (male: 12, female: 3) with benign thyroid nodules were eligible to join this study. These nodules were categorized as cystic (n<!--> <!-->=<!--> <!-->9), solid (n<!--> <!-->=<!--> <!-->3), or mixed (n<!--> <!-->=<!--> <!-->3). Median nodules volume was 6.59<!--> <!-->ml (range: 0.56-55<!--> <!-->ml). Predicted absorbed dosee to the nodules varied between 10 to 1036<!--> <!-->Gy. The VRRs at 3. months was 85% for all nodule types with gradual increases over time: 0-92%, 20-97%, and 28-98% at 1. week, 1. month, and 3-months, respectively. The median VRR of cystic nodules was 89% (range: 81%-98%) at 3-months. It is significantly higher than solid ones (p<!--> <!-->=<!--> <!-->0.009). None of the patients experienced adverse reactions or discomfort during the injection or follow-up.</p></div><div><h3>Conclusion</h3><p>LUTMA treatment significantly reduces the volume of benign thyroid nodules, offering relief from disease-associated symptoms and cosmetic concerns. It emerges as a promising alternative to surgical and other local treatments for benign thyroid nodule ablation.</p></div><div><h3>Clinical signification</h3><p>LUTMA is a novel theranostic radiopharmaceutical which is promising in local ablative treatment of benign thyroid nodules.</p></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500023"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141702469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rabdomiosarcoma prostático en un paciente de seis años evaluado mediante [18F]FDG PET/TC 通过[18F]FDG PET/CT 评估一名六岁患者的前列腺横纹肌肉瘤
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500016
{"title":"Rabdomiosarcoma prostático en un paciente de seis años evaluado mediante [18F]FDG PET/TC","authors":"","doi":"10.1016/j.remn.2024.500016","DOIUrl":"10.1016/j.remn.2024.500016","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500016"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141415622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Características de la imagen de un angiolipoma espinal atípico en PET/TC y resonancia magnética (RM) 非典型脊柱血管脂肪瘤在 PET/CT 和磁共振成像(MRI)上的成像特征
IF 1.6 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-07-01 DOI: 10.1016/j.remn.2024.500015
Y. Li , R. Luo , W. Zhang, L. Li
{"title":"Características de la imagen de un angiolipoma espinal atípico en PET/TC y resonancia magnética (RM)","authors":"Y. Li ,&nbsp;R. Luo ,&nbsp;W. Zhang,&nbsp;L. Li","doi":"10.1016/j.remn.2024.500015","DOIUrl":"10.1016/j.remn.2024.500015","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 4","pages":"Article 500015"},"PeriodicalIF":1.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilidad de la gammagrafía ósea como reflejo del estado nutritivo del paciente, un caso de escorbuto 骨闪烁成像在反映患者营养状况方面的作用,一个坏血病病例。
IF 1.2 4区 医学
Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-05-01 DOI: 10.1016/j.remn.2024.500012
J.A. Vázquez Gómez , M. Salvá Arteaga , I. Roncero Sánchez-Cano , A. Fernández Marín , M.P. Garrastachu Zumarán , M.Y. Ruiz del Prado
{"title":"Utilidad de la gammagrafía ósea como reflejo del estado nutritivo del paciente, un caso de escorbuto","authors":"J.A. Vázquez Gómez ,&nbsp;M. Salvá Arteaga ,&nbsp;I. Roncero Sánchez-Cano ,&nbsp;A. Fernández Marín ,&nbsp;M.P. Garrastachu Zumarán ,&nbsp;M.Y. Ruiz del Prado","doi":"10.1016/j.remn.2024.500012","DOIUrl":"https://doi.org/10.1016/j.remn.2024.500012","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 3","pages":"Article 500012"},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141072504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信